Cite
HARVARD Citation
Groll, A. et al. (n.d.). 623. Preliminary Dosing for Adolescent Hematopoietic Stem-Cell Transplant (HSCT) Recipients Based on Pharmacokinetic (PK), Safety, and Efficacy Data of Letermovir (LET) for Cytomegalovirus (CMV) Prophylaxis. Open forum infectious diseases. p. . [Online].